BEIJING (Reuters) - China's top disease control official has said the country is formally considering mixing COVID-19 vaccines as a way of further boosting vaccine efficacy. Available data shows ...

A Moderna COVID-19 vaccine (brand name: Spikevax) photographed at Borinquen Health Care Center on May 29 in Miami. (Photo illustration by Joe Raedle/Getty Images) The Food and Drug Administration ...

Vaccine expert Hu Haitao, who studied under Drew Weissman, the Nobel laureate and pioneer of mRNA biology, has given up his tenured position at a US research institute and returned to China – a ...

The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

WASHINGTON – President Donald Trump said Sept. 1 he is now demanding that COVID-19 vaccine manufacturers prove that their shots have been effective, adding to his long string of comments alternately ...

BEIJING, Sept 29 (Reuters) - China's Shenzhen Kangtai Biological Products (300601.SZ), opens new tab said on Tuesday it planned to launch a clinical trial of its coronavirus vaccine candidate as soon ...

New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...